Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists

被引:24
|
作者
Xia, Lizi [1 ]
Burger, Wessel A. C. [1 ]
van Veldhoven, Jacobus P. D. [1 ]
Kuiper, Boaz J. [1 ]
van Duijl, Tirsa T. [1 ]
Lenselink, Eelke B. [1 ]
Paasman, Ellen [1 ]
Heitman, Laura H. [1 ]
IJzerman, Adriaan P. [1 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands
关键词
PROTEIN-COUPLED RECEPTOR; TARGET RESIDENCE TIME; MEDICINAL CHEMISTRY; CLICK CHEMISTRY; LIGAND; BINDING; RADIOLIGAND; THERMODYNAMICS; GPCRDB;
D O I
10.1021/acs.jmedchem.7b00950
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We expanded on a series of pyrido[2,1-f]purine-2,4-clione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [S-35]GTP gamma S binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)-k(off)-K-D kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds' binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery.
引用
收藏
页码:7555 / 7568
页数:14
相关论文
共 47 条
  • [21] 2-Aryladenine derivatives as a potent scaffold for A1, A3 and dual A1/A3 adenosine receptor antagonists: Synthesis and structure-activity relationships
    Areias, Filipe
    Correia, Carla
    Rocha, Ashly
    Brea, Jose
    Castro, Marian
    Loza, Maria, I
    Fernanda Proenca, M.
    Alice Carvalho, M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (16) : 3551 - 3558
  • [22] Phenylethyl-substituted pyrimido|2,1-f|purinediones and related compounds:: Structure-activity relationships as adenosine A1 and A2A receptor ligands
    Drabczynska, Anna
    Mueller, Christa E.
    Schiedel, Anke
    Schumacher, Britta
    Karolak-Wojciechowska, Janina
    Fruzinski, Andrzej
    Zobnin, Weronika
    Yuzlenko, Olga
    Kiec-Kononowicz, Katarzyna
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (22) : 6956 - 6974
  • [23] Structure-Activity Relationships of Truncated D- and L-4′-Thioadenosine Derivatives as Species-Independent A3 Adenosine Receptor Antagonists
    Jeong, Lak Shin
    Pal, Shantanu
    Choe, Seung Ah
    Choi, Won Jun
    Jacobson, Kenneth A.
    Gao, Zhan-Guo
    Klutz, Athena M.
    Hou, Xiyan
    Kim, Hea Ok
    Lee, Hyuk Woo
    Lee, Sang Kook
    Tosh, Dilip K.
    Moon, Hyung Ryong
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) : 6609 - 6613
  • [24] Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents
    Zagorska, Agnieszka
    Bucki, Adam
    Kolaczkowski, Marcin
    Siwek, Agata
    Gluch-Lutwin, Monika
    Starowicz, Gabriela
    Kazek, Grzegorz
    Partyka, Anna
    Wesolowska, Anna
    Sloczynska, Karolina
    Pekala, Elzbieta
    Pawlowski, Maciej
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 : 10 - 24
  • [25] A SEARCH OF NEW DRUGS IN GROUP OF XANTHINE DERIVATIVES .25. 1,3-DIMETHYL-6,7,8,9-TETRAHYDROPYRIMIDO-(2,1-F)-PURINE-2,4-(1H,3H)-DIONE AND ITS DERIVATIVES
    ECKSTEIN, M
    LOSON, W
    DISSERTATIONES PHARMACEUTICAE ET PHARMACOLOGICAE, 1968, 20 (01): : 35 - &
  • [26] Synthesis and structure-affinity relationships of 4-(5-aryl-1,2,3,6-tetrahydropyridino)pyrimidine derivatives as corticotropin-releasing factor1 receptor antagonists
    Kumagai, T
    Okubo, T
    Kataoka-Okubo, H
    Chaki, S
    Okuyama, S
    Nakazato, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (05) : 1349 - 1355
  • [27] Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists
    Müller, CE
    Geis, U
    Hipp, J
    Schobert, U
    Frobenius, W
    Pawlowski, M
    Suzuki, F
    Sandoval-Ramírez, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (26) : 4396 - 4405
  • [28] Structure-activity relationships of 2-chloro-N6-substituted-4′-thioadenosine-5"-dialkylamides as potent and selective human A3 adenosine receptor antagonists
    Tosh, Dilip K.
    Lee, Hyuk Woo
    Hou, Xiyan
    Pei, Xiaoyuan
    Jacobson, Kenneth A.
    Jeong, Lak Shin
    DRUGS OF THE FUTURE, 2007, 32 : 53 - 53
  • [29] SEARCH FOR NEW DRUGS IN GROUP OF XANTHINE DERIVATIVES .35. NEW METHOD OF SYNTHESIS OF 6,7,8,9-TETRAHYDROPYRIMIDO [2,1-F]-PURINE-2,4-(1H,3H)-DIONE SYSTEM
    ECKSTEIN, M
    DRABCZYNSKA, A
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1973, 25 (02): : 171 - 173
  • [30] Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonists
    Nakazato, A
    Kumagai, T
    Okubo, T
    Tanaka, H
    Chaki, S
    Okuyama, S
    Tomisawa, K
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (05) : 1183 - 1193